More than 36 million Americans suffer from migraine headaches. They can be debilitating, costing about $20 billion a year in medical expenses and lost productivity. In this WVU Medicine Health Report, Dr. John Phillips explains why Botox is becoming a more common treatment for chronic migraine and how Dr. Umer Najib at the WVU Headache Center helped a patient live a pain free life after treatment.